Decreased SUMOylation of the retinoblastoma protein in keratinocytes during the pathogenesis of vitiligo

Zhou,Miaoni; Lin,Fuquan; Xu,Wen; Jin,Rong; Xu,Aie

doi:10.3892/mmr.2018.9299

Decreased SUMOylation of the retinoblastoma protein in keratinocytes during the pathogenesis of vitiligo

Authors:
- Miaoni Zhou
- Fuquan Lin
- Wen Xu
- Rong Jin
- Aie Xu
View Affiliations

Affiliations: Department of Dermatology, Hangzhou Institute of Dermatology and Venereology, Third People's Hospital of Hangzhou, Hangzhou, Zhejiang 310009, P.R. China
Published online on: July 19, 2018 https://doi.org/10.3892/mmr.2018.9299
Pages: 3469-3475

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The role of SUMOylation in the pathogenesis of vitiligo has not been reported previously. The present study aimed to reveal abnormalities in small ubiquitin‑like modifier (SUMO) conjugation in keratinocytes from depigmented lesions of patients with vitiligo and confirm the role of SUMOylation in keratinocytes from patients with vitiligo. Skin samples used for immunohistochemistry were obtained by punch biopsy from the depigmented lesions of 6 patients. Blisters were produced by vacuum and the roofs were collected for keratinocyte culture. HaCaT cells were transduced with SUMO1 knockdown vectors. The protein expression of SUMO1, SUMO‑specific peptidase 1 (SENP1), ubiquitin‑conjugating enzyme E2 I (Ubc9), SUMO‑activating enzyme subunit 1 (SAE1), cyclin‑dependent kinase (CDK)2, CDK6, proliferating cell nuclear antigen (PCNA), retinoblastoma protein (Rb), phosphorylated Rb (pRb) and β‑actin was assessed by western blotting. The SUMOylation status of proteins was assessed by immunoprecipitation. Cell cycle analysis was performed by flow cytometry and cell proliferation rate was investigated using a Cell Counting Kit‑8. The results demonstrated that the levels of SUMO1‑conjugated proteins were decreased in vitiligo lesions and vitiligo keratinocytes compared with normal controls. The protein expression of Ubc9 was decreased and SENP1 was increased in vitiligo keratinocytes compared with normal keratinocytes, with no alterations in SAE1 expression. Following knockdown of SUMO1 in HaCaT cells, the proliferation of HaCaT cells was reduced and the cell cycle was arrested in G1 phase. Furthermore, the protein expression levels of PCNA, CDK2, CDK6 and pRb were reduced in SUMO1‑knockdown HaCaT cells, and SUMOylated Rb was also decreased markedly in keratinocytes from lesions of patients with vitiligo compared with normal keratinocytes. In conclusion, vitiligo lesions in the present study exhibited dysregulated SUMOylation and deSUMOylation balance and dysregulation of cell cycle progression may be present in SUMO1 knockdown HaCaT cells. These results indicate that deSUMOylation of Rb of keratinocytes may serve an important role in vitiligo, providing a novel direction for the study into the mechanism of vitiligo.

View Figures

View References

1	Lazzeri L, Colucci R, Cammi A, Dragoni F and Moretti S: Adult onset vitiligo: Multivariate analysis suggests the need for a thyroid screening. Biomed Res Int. 2016:80657652016. View Article : Google Scholar : PubMed/NCBI
2	Lee AY: Role of keratinocytes in the development of vitiligo. Ann Dermatol. 24:115–125. 2012. View Article : Google Scholar : PubMed/NCBI
3	Hirobe T: Keratinocytes regulate the function of melanocytes. Dermatologica Sinica. 32:200–204. 2014. View Article : Google Scholar
4	Shin YH, Seo YK, Yoon HH, Song KY and Park JK: Effect of keratinocytes on regulation of melanogenesis in culture of melanocytes. Biotech Bioproc Eng. 17:203–210. 2012. View Article : Google Scholar
5	Prignano F, Pescitelli L, Becatti M, Di Gennaro P, Fiorillo C, Taddei N and Lotti T: Ultrastructural and functional alterations of mitochondria in perilesional vitiligo skin. J Dermatol Sci. 54:157–167. 2009. View Article : Google Scholar : PubMed/NCBI
6	Lee AY, Kim NH, Choi WI and Youm YH: Less keratinocyte-derived factors related to more keratinocyte apoptosis in depigmented than normally pigmented suction-blistered epidermis may cause passive melanocyte death in vitiligo. J Invest Dermatol. 124:976–983. 2005. View Article : Google Scholar : PubMed/NCBI
7	Raman N, Nayak A and Muller S: The SUMO system: A master organizer of nuclear protein assemblies. Chromosoma. 122:475–485. 2013. View Article : Google Scholar : PubMed/NCBI
8	Schimmel J, Eifler K, Sigurðsson JO, Cuijpers SA, Hendriks IA, Verlaan-de Vries M, Kelstrup CD, Francavilla C, Medema RH, Olsen JV and Vertegaal AC: Uncovering SUMOylation dynamics during cell-cycle progression reveals FoxM1 as a key mitotic SUMO target protein. Mol Cell. 53:1053–1066. 2014. View Article : Google Scholar : PubMed/NCBI
9	Cubeñas-Potts C and Matunis MJ: SUMO: A multifaceted modifier of chromatin structure and function. Dev Cell. 24:1–12. 2013. View Article : Google Scholar : PubMed/NCBI
10	Chen CH, Chang CC, Lee TH, Luo M, Huang P, Liao PH, Wei S, Li FA, Chen RH, Zhou XZ, et al: SENP1 deSUMOylates and regulates Pin1 protein activity and cellular function. Cancer Res. 73:3951–3962. 2013. View Article : Google Scholar : PubMed/NCBI
11	He X, Riceberg J, Pulukuri SM, Grossman S, Shinde V, Shah P, Brownell JE, Dick L, Newcomb J and Bence N: Characterization of the loss of SUMO pathway function on cancer cells and tumor proliferation. PLoS One. 10:e01238822015. View Article : Google Scholar : PubMed/NCBI
12	Eifler K and Vertegaal ACO: SUMOylation-mediated regulation of cell cycle progression and cancer. Trends Biochem Sci. 40:779–793. 2015. View Article : Google Scholar : PubMed/NCBI
13	Bellail AC, Olson JJ and Hao C: SUMO1 modification stabilizes CDK6 protein and drives the cell cycle and glioblastoma progression. Nat Commun. 5:42342014. View Article : Google Scholar : PubMed/NCBI
14	Deyrieux AF, Rosas-Acosta G, Ozbun MA and Wilson VG: Sumoylation dynamics during keratinocyte differentiation. J Cell Sci. 120:125–136. 2007. View Article : Google Scholar : PubMed/NCBI
15	Taieb A, Alomar A, Böhm M, Dell'anna ML, De Pase A, Eleftheriadou V, Ezzedine K, Gauthier Y, Gawkrodger DJ, Jouary T, et al: Guidelines for the management of vitiligo: The European dermatology forum consensus. Br J Dermatol. 168:5–19. 2013. View Article : Google Scholar : PubMed/NCBI
16	Taïeb A and Picardo M: Clinical practice. Vitiligo. N Engl J Med. 360:160–169. 2009. View Article : Google Scholar : PubMed/NCBI
17	Lim S and Kaldis P: Cdks, cyclins and CKIs: Roles beyond cell cycle regulation. Development. 140:3079–3093. 2013. View Article : Google Scholar : PubMed/NCBI
18	Meng F, Qian J, Yue H, Li X and Xue K: SUMOylation of Rb enhances its binding with CDK2 and phosphorylation at early G1 phase. Cell Cycle. 15:1724–1732. 2016. View Article : Google Scholar : PubMed/NCBI
19	Kim KI and Baek SH: Small ubiquitin-like modifiers in cellular malignancy and metastasis. Int Rev Cell Mol Biol. 273:265–311. 2009. View Article : Google Scholar : PubMed/NCBI
20	Neyret-Kahn H, Benhamed M, Ye T, Le Gras S, Cossec JC, Lapaquette P, Bischof O, Ouspenskaia M, Dasso M, Seeler J, et al: Sumoylation at chromatin governs coordinated repression of a transcriptional program essential for cell growth and proliferation. Genome Res. 23:1563–1579. 2013. View Article : Google Scholar : PubMed/NCBI
21	Asghar U, Witkiewicz AK, Turner NC and Knudsen ES: The history and future of targeting cyclin-dependent kinases in cancer therapy. Nat Rev Drug Discov. 14:130–146. 2015. View Article : Google Scholar : PubMed/NCBI
22	Hendriks IA, D'Souza RC, Yang B, Verlaan-de Vries M, Mann M and Vertegaal AC: Uncovering global SUMOylation signaling networks in a site-specific manner. Nat Struct Mol Biol. 21:927–936. 2014. View Article : Google Scholar : PubMed/NCBI
23	Evdokimov E, Sharma P, Lockett SJ, Lualdi M and Kuehn MR: Loss of SUMO1 in mice affects RanGAP1 localization and formation of PML nuclear bodies, but is not lethal as it can be compensated by SUMO2 or SUMO3. J Cell Sci. 121:4106–4113. 2008. View Article : Google Scholar : PubMed/NCBI
24	Zhang FP, Mikkonen L, Toppari J, Palvimo JJ, Thesleff I and Jänne OA: Sumo-1 function is dispensable in normal mouse development. Mol Cell Biol. 28:5381–5390. 2008. View Article : Google Scholar : PubMed/NCBI
25	Giacinti C and Giordano A: RB and cell cycle progression. Oncogene. 25:5220–5227. 2006. View Article : Google Scholar : PubMed/NCBI
26	Armstrong AA, Mohideen F and Lima CD: Recognition of SUMO-modified PCNA requires tandem receptor motifs in Srs2. Nature. 483:59–63. 2012. View Article : Google Scholar : PubMed/NCBI